U.S. equities advanced on Monday after the U.S. and Iran halted their military campaign against each other in recent days, ...

ASML Holding shows that AI has now re-energized its AI game plan, providing multi-year clarity in its net system sales ...

MacroGenics is a Buy, reflecting an extended cash runway to 2028 and upside from B7-H3 ADC MGC026 with 2026 data catalyst.

LLMs are an engine of great economic value, but the labs might be left with virtually none of it. I want to emphasize that ...

Strong Buy: shares trade at a steep discount as ACI Edge targets $200M savings by 2027, with private label upside.

Waste Management is scheduled to announce Q2 earnings results on Tuesday, July 28th, after market close. Wall Street, on average, expects the semiconductor company to post a quart ...

European wholesale natural gas prices fell sharply on hopes that a pause in fighting between the US and Iran could pave the ...

AT&T demonstrates resilient FCF growth, robust fiber expansion, and a disciplined focus on core connectivity businesses. Read ...

Novo Nordisk (NVO) is rated a Modest Buy with a raised price target of $80, driven by oral Wegovy’s rapid market adoption.

Steve Eisman warns the stock market could plunge if hyperscalers cut AI capex, citing Nvidia risk and LLM price wars.

Wall Street was higher on Monday as the U.S. and Iran halted their military campaign against each other for the last few days ...